VAM
ISEE

Visium Asset Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Visium Asset Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-24,113
Closed -$780K – 1061
2013
Q4 		$780K Buy
+24,113
New +$715K 0.02% 497

Other funds holding ISEE

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
JCG
JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Visium Asset Management's ISEE Position: Q1 2014 in Review

Visium Asset Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2014, closing a stake of 24,113 shares — an estimated $780K sold.

Visium Asset Management first reported a position in ISEE in Q4 2013 and held it in 1 quarter. The position peaked at $780K in Q4 2013. 73 funds tracked by Wall St. Rank hold ISEE as of Q1 2014.

  • Visium Asset Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2014 after selling out during the quarter.
  • Visium Asset Management sold 24,113 IVERIC bio, Inc. Common Stock shares in Q1 2014, an estimated $780K.
  • Visium Asset Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 1 quarter.
  • Visium Asset Management's IVERIC bio, Inc. Common Stock position peaked at $780K in Q4 2013.
  • 73 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2014.

Based on Visium Asset Management's 13F filing for Q1 2014, filed 15 May 2014.